Indoco Remedies gets USFDA ANDA nod for Glycopyrrolate Injection Medical Dialogues Bureau3 Nov 2019 4:30 AM GMTGlycopyrrolate is indicated for use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions; to reduce the...
Indoco Remedies successfully completes USFDA inspection of CRO Anacipher in Hyderabad Medical Dialogues Bureau13 Aug 2019 4:15 AM GMT"This is the fourth successive USFDA inspection with ZERO 483 for our CRO – AnaCipher," stated Ms Aditi Kare Panandikar, Managing Director, Indoco...
USFDA issues warning letter to Indoco Remedies for Goa plant Medical Dialogues Bureau16 July 2019 6:09 AM GMTThe facility had received six observations in Form 483s and was classified as Official Action Indicated in March. Indoco Remedies responded to these...
USFDA inspected Goa facility, no observations issued: Indoco Remedies Farhat Nasim30 March 2019 6:22 AM GMTThe US Food and Drug Administration (USFDA) has cleared the Goa-based sterile manufacturing facility of Indoco Remedies for finished dosages.New...
Indoco Remedies gets two minor observations from USFDA for Goa plants Medical Dialogues Bureau25 Nov 2018 3:37 AM GMTMumbai: Drug firm Indoco Remedies on Thursday said it has received two minor observations from the US health regulator for its Goa-based two plants....